Mary Linton Peters
16PUBLICATIONS
97CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (16)
Sort by Publication Date:
|Feb 13, 2026
A Phase II Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2.Brandon M Huffman, Miklos Diossy, Matthew B Yurgelun
|Sep 02, 2025
Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer.Rishi Surana, Micaela Morgado, Ashwin Somasundaram
|Jul 10, 2025
Prognostic Role of MTAP Loss in Cholangiocarcinoma.James Lyon, Soravis Osataphan, Vaibhav Birda
|May 29, 2025
PD-L1 Expression in Biliary Tract Cancer: Comparison Across Antibody Clones and Role as a Predictor of Response to Chemoimmunotherapy: A Meta-Analysis.Juan J Juarez-Vignon Whaley, Soravis Osataphan, Ben Ponvilawan
|Aug 10, 2024
Somatic Mutation Profile as a Predictor of Treatment Response and Survival in Unresectable Pancreatic Ductal Adenocarcinoma Treated with FOLFIRINOX and Gemcitabine Nab-Paclitaxel.Rodrigo Paredes de la Fuente, Santiago Sucre, Cristina Ponce
|May 02, 2024
Efficacy of dual checkpoint inhibitors in a patient with a mixed hepatocellular cholangiocarcinoma.Santiago Sucre, Andrea Bullock, Mary Linton Peters
Pageof 3
Frequent Collaborators
3 joint publications
Rodrigo Paredes de la Fuente
3 joint publications
Andrea J Bullock
2 joint publications
Virginia Speare
2 joint publications
Anuj K Patel
2 joint publications
Jeffrey W Clark
2 joint publications
Soravis Osataphan
2 joint publications
Matthew B Yurgelun
2 joint publications
Ahmed Rattani
2 joint publications
Benjamin Schlechter
2 joint publications
Bruno Bockorny
